Pharmaceuticals

Revenue of the Quinolones Market Predicted to Achieve $66.44 Billion by 2030, Driven by 5.1% CAGR

February 24, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the quinolones market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Quinolones Market size between 2026 and 2035?

The quinolones market size has experienced consistent expansion in recent years. It is projected to grow from $51.89 billion in 2025 to $54.48 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 5.0%. Historically, this growth has been driven by factors such as the increasing prevalence of bacterial infections, a rise in hospital admissions, the strong demand for broad-spectrum antibiotics, the expansion of retail pharmacies, and various government initiatives for infectious disease control.

The quinolones market is anticipated to experience robust growth over the next few years, with its size projected to reach $66.44 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.1%. This expansion during the forecast period is primarily driven by advancements in precision medicine, the development of new quinolone formulations, the broadening of online pharmacy channels, increasing awareness regarding antimicrobial stewardship, and the growing adoption of digital health monitoring tools. Concurrently, major trends expected in this period involve enhanced antibiotic resistance management, wider availability of generic drugs, personalized treatment approaches, an increase in outpatient and home healthcare services, and greater investment in research and development for novel quinolones.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp

Which Drivers Are Impacting Market Performance In The Quinolones Market?

The escalating threat posed by antimicrobial resistance (AMR) is projected to fuel the expansion of the quinolones market in the future. AMR denotes the capacity of various microorganisms, including bacteria, viruses, parasites, and fungi, to withstand the action of antimicrobial medications. Quinolones possess a wide range of activity, rendering them potent against numerous bacterial types. When prescribed for particular infections, they can permeate different tissues, establishing them as a favored option when alternatives are scarce. An illustrative example is from October 2025, when the World Health Organization, a US-based intergovernmental organization, published a thorough worldwide analysis that investigated the prevalence and patterns of antibiotic resistance. This study utilized information from over 23 million verified instances of bloodstream, urinary tract, and gastrointestinal infections, as well as urogenital gonorrhea. The conclusions of this analysis were drawn from reports submitted by 104 countries in 2023. Consequently, the heightened risk of antimicrobial resistance is propelling the expansion of the quinolones market.

What Segment Types Are Examined In The Quinolones Market?

The quinolones market covered in this report is segmented –

1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types

2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen

3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What Long-Term Trends Are Expected To Shape The Future Of The Quinolones Market?

Companies operating within the quinolones market are concentrating on innovative offerings like fluoroquinolone antibiotic eye drops to enhance their market revenues. These particular antibiotic eye drops are a class of antibiotics used to address bacterial infections of the eye. For example, in July 2023, Harrow Health Inc., a US-based pharmaceutical company, introduced Vigamox. The solution is isotonic, with an osmolality of approximately 290 mOsm/kg, and contains 5.45 mg moxifloxacin hydrochloride, which is equivalent to 5 mg moxifloxacin base. This medication is supplied in a 3-milliliter bottle and is dispensed as a sterile ophthalmic solution through a system consisting of a tan polypropylene closure, a dispensing plug, and a natural low-density polyethylene bottle. Vigamox is recommended for preventing eye infections both before and after surgical procedures.

Who Are The Core Companies Influencing Trends In The Quinolones Market?

Major companies operating in the quinolones market are Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report

Which Regions Are Projected To Dominate The Quinolones Market In The Coming Years?

North America was the largest region in the quinolones market in 2025. The regions covered in the quinolones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Quinolones Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9429&type=smp

Browse Through More Reports Similar to the Global Quinolones Market 2026, By The Business Research Company

Quinolones Market Report 2026

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report

Quinoa Market Report 2026

https://www.thebusinessresearchcompany.com/report/quinoa-global-market-report

Fluoxetine Market Report 2026

https://www.thebusinessresearchcompany.com/report/fluoxetine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795